Canaccord initiated coverage of Curaleaf (CURLF) with a Buy rating and C$5 price target The winds of regulatory change are finally starting to blow and any material change to the backdrop ahead of the midterm elections will drive a re-rating of the space, the analyst tells investors in a research note. Curaleaf continues to elevate its offering, which should allow the company to better moat its footprint and either remain the cannabis destination of choice for consumers.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURLF:
- Curaleaf Announces Executive Securities Disposition Plan
- Curaleaf to Announce Q3 2025 Financial Results
- Curaleaf opens new dispensaries in Florida and Ohio
- Curaleaf Joins S&P/TSX Composite Index, Boosting Cannabis Industry Credibility
- Curaleaf Joins S&P/TSX Composite Index, Boosting Market Visibility